Catherine “Kate” Gunn is an internationally recognized board director, C-suite executive, entrepreneur, and governance leader with more than 25 years of experience guiding organizations through growth, transformation, commercialization, and strategic innovation. With an uncommon combination of scientific credibility, operational excellence, and entrepreneurial vision, Kate has established herself as a trusted advisor to boards and executive leadership teams navigating the evolving intersection of healthcare, artificial intelligence, biotechnology, deep technology, and digital transformation. Her career reflects an unwavering commitment to building organizations that deliver both sustainable commercial success and meaningful societal impact.
Throughout her career, Kate has successfully bridged the worlds of science, technology, healthcare, and governance. Her professional journey began with leadership positions in global technology and financial services organizations, including Morgan Stanley International, PeopleSoft (Oracle), and Western Sydney University, where she gained extensive experience in business development, commercialization, technology transfer, and organizational strategy. These foundational roles provided her with a deep understanding of complex enterprises, global markets, and the strategic disciplines required to scale innovation into commercially successful organizations.
Kate is perhaps best known as the Founder, Chief Executive Officer, and Executive Chair of Balance! Healthcare, where she transformed an entrepreneurial vision into a thriving multidisciplinary healthcare organization serving communities across Australia. Under her leadership, the company secured more than $15 million in grant funding, developed four three integrated healthcare practices, launched an Urgent Care Clinic, and built a highly respected organization employing approximately over 100 professionals. Her leadership extended beyond business growth to include navigating major healthcare reforms, pandemic response planning, natural disaster management, infrastructure development, capital raising, and long-term enterprise sustainability. Her ability to anticipate risk while positioning organizations for future growth has become one of the defining characteristics of her executive career.
In addition to her entrepreneurial accomplishments, Kate has held several highly influential executive leadership positions within internationally recognized medical research institutions. As Chief Operating Officer and Corporate Secretary of the Children’s Medical Research Institute, she oversaw strategic operations for a globally respected organization dedicated to advancing gene therapy, cancer research, and pediatric medicine. During her tenure, she significantly expanded philanthropic funding, accelerated commercialization initiatives through biotechnology spin-outs, strengthened operational performance, implemented enterprise-wide Salesforce platforms, and played a central role in planning a $270 million gene technologies facility designed to accelerate scientific discovery and global partnerships.
Her previous executive leadership roles at the Garvan Institute of Medical Research and the ARC Centre of Excellence for All-sky Astrophysics (CAASTRO) further demonstrate her remarkable versatility. Whether managing multimillion-dollar research enterprises, commercializing scientific innovation, building international collaborations, or establishing governance structures for newly formed organizations, Kate consistently delivered measurable improvements in operational efficiency, financial sustainability, stakeholder engagement, and organizational performance. Her rare ability to lead successfully across both biomedical research and astrophysics reflects a unique blend of intellectual curiosity, disciplined execution, and strategic thinking.
Governance has remained a consistent thread throughout Kate’s distinguished career. She has served as Chair, Director, and Corporate Secretary, and Board Observer across numerous private companies, nonprofit organizations, research institutions, foundations, and international ventures. Her board experience spans healthcare, biotechnology, philanthropy, education, life sciences, software, and emerging technologies. She has contributed to Audit Committees, Nominating and Governance Committees, Digital Technology Committees, and philanthropic foundations while helping organizations strengthen governance frameworks, improve board effectiveness, and align strategy with long-term stakeholder value.
Kate has become a recognized leader in the rapidly evolving field of AI governance and digital oversight. Long before artificial intelligence became a boardroom imperative, she was developing governance frameworks that integrated cybersecurity, responsible AI, enterprise risk management, data governance, and ethical technology deployment into board-level decision making. She has pioneered Digital Technology Committees, led cybersecurity simulation exercises for directors and executives, implemented AI governance policies across healthcare organizations, and championed governance models that enable innovation without compromising safety, compliance, or stakeholder trust. Her expertise places her at the forefront of helping boards responsibly oversee emerging technologies while creating sustainable competitive advantage.
Her entrepreneurial mindset continues to influence organizations well beyond those she directly leads. Through Larkfield Consulting, where she serves as U.S. Country Manager, Kate advises founders, investors, healthcare organizations, biotechnology companies, and AI-driven ventures on commercialization, digital transformation, governance, operational scaling, capital readiness, and strategic growth. She also serves as a business mentor for organizations including the MIT and Harvard-affiliated TNT program, the Start-Up World Cup, and the American College of Healthcare Executives. Her passion for helping founders successfully navigate growth challenges reflects her belief that experienced leadership can accelerate innovation while avoiding common scaling pitfalls.
Kate’s leadership extends internationally through decades of experience across Australia, New Zealand, Singapore, China, the United Kingdom, Europe, and the United States. Her work has included international technology partnerships, research collaborations, commercialization initiatives, cross-border governance, and global stakeholder engagement. This international perspective enables her to appreciate cultural differences while identifying universal governance principles that drive organizational excellence across industries and markets.
Her commitment to professional excellence is reflected in an exceptional academic and governance portfolio. Kate holds a Master of Business Administration from Macquarie Graduate School of Management, completed executive education through Harvard Business School’s Women’s Leadership Program, attended Wharton Executive Education for Corporate Valuation, is a National Association of Corporate Directors Certified Director (NACD.DC), and is a Fellow of the Australian Institute of Company Directors (FAICD). She also holds Registered Technology Transfer Professional (RTTP) certification, underscoring her expertise in innovation commercialization and intellectual property strategy.
Kate’s accomplishments have earned significant recognition throughout her career, including being named one of the Australian Financial Review and Westpac’s 100 Women of Influence, receiving a Harvard Business School Women’s Leadership Program Scholarship, recognition as a Telstra Business Woman of the Year finalist, Blue Mountains Business Leader of the Year, and the University of Sydney Vice-Chancellor’s Award for Outstanding Contribution to Research Excellence. These honors reflect not only her business success but also her ability to lead organizations that create meaningful value for employees, investors, researchers, patients, and communities alike.
Today, Kate continues to focus on helping organizations navigate the future of healthcare, artificial intelligence, deep technology, and digital transformation. She actively seeks opportunities to serve on corporate boards where her experience in governance, commercialization, AI oversight, cybersecurity, mergers and acquisitions, startup development, and healthcare leadership can help organizations responsibly innovate while delivering sustainable growth. Driven by a genuine desire to give back, expand her board leadership, and mentor the next generation of founders and executives, Kate remains committed to helping organizations transform scientific discovery and technological innovation into lasting commercial and societal impact.
Character:
Kate leads with integrity, resilience, and an unwavering commitment to ethical leadership in every organization she serves. She consistently earns the trust of boards, executives, investors, and stakeholders through thoughtful decision-making, accountability, and a collaborative leadership style.
Knowledge:
Her expertise spans healthcare, biotechnology, artificial intelligence, cybersecurity, commercialization, governance, and digital transformation, giving her an exceptionally broad strategic perspective. She combines deep scientific understanding with practical executive experience to solve complex organizational challenges.
Strategic:
Kate excels at identifying opportunities where innovation, governance, and disciplined execution intersect to create long-term value. She brings a proven ability to guide startups, growth-stage companies, and established organizations through transformation while effectively managing risk and positioning them for sustainable success.
Communication:
An experienced executive presenter and boardroom communicator, Kate translates highly technical concepts into clear strategic insights for diverse audiences. Her ability to engage directors, executives, investors, founders, policymakers, and stakeholders enables organizations to build alignment, strengthen governance, and execute with confidence.
